A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease
Violante Olivari, Simona Maria Di Modica, Maria Rosa Lidonnici, Mariam Aghajan, Celia Cordero-Sánchez, Emanuele Tanzi, Mariateresa Pettinato, Alessia Pagani, Francesca Tiboni, Laura Silvestri, Shuling Guo, Giuliana Ferrari, Antonella Nai
Topics & Concepts
HepcidinErythropoiesisAnemiaErythropoietinFerroportinMedicineTransferrin receptorInternal medicineAnemia of chronic diseaseEndocrinologyHaematopoiesisInflammationProinflammatory cytokineIneffective erythropoiesisImmunologyTransferrinBiologyStem cellCell biologyIron Metabolism and DisordersHemoglobinopathies and Related DisordersErythropoietin and Anemia Treatment